Walters Dunn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Walters Dunn. Real-time updates on events, politics, business and more.

FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis

June 18, 2022

An FDA advisory panel has rejected the atypical antipsychotic pimavanserin for the treatment of Alzheimer’s disease psychosis.

Johns Hopkins University United States West Los Angeles Madhavr Thambisetty Howard Fillit Los Angeles

Source: medscape.com

FDA Advisers Reject Nuplazid for Alzheimer's Disease Psychosis

June 17, 2022

Weak trial data not enough to persuade panel to recommend approval

New York United States University Of Arizona Madhavr Thambisetty Paul Stander Walters Dunn

Source: medpagetoday.com

Prader-Willi Syndrome Drug Receives a Resounding 'No' from FDA Advisory Panel

November 5, 2021

An FDA advisory panel has voted overwhelmingly against a new drug application for intranasal carbetocin, intended to treat symptoms associated with Prader-Willi Syndrome.

United States Los Angeles Jessg Fiedorowicz Alice Shapley Paulb Bossie Walters Dunn

Source: medscape.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Walters Dunn News Today

FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis

FDA Advisers Reject Nuplazid for Alzheimer's Disease Psychosis

Prader-Willi Syndrome Drug Receives a Resounding 'No' from FDA Advisory Panel

Explore More Categories